With gratitude to Aids Fonds for hosting, the International AIDS Vaccine Initiative has the pleasure to invite you to a session with Dr. Anatoli Kamali, IAVI’s Regional Director in Eastern Africa. Based on almost 30 years of work experience in HIV/AIDS research, Anatoli will provide a first-hand account on the state of HIV prevention in Eastern Africa.
09.00 – 09.30: Arrival with tea and coffee
09.30 – 09.40: Welcome and introductions: Hester Kuipers, Executive Director, IAVI Europe
09.40 – 10.20: Presentation Dr. Anatoli Kamali, Regional Director, IAVI Africa
10.20 – 11.00: Q&A
Please click here for the Programme Aidsfonds May 16 Anatoli Kamali in pdf.
Anatoli is the Regional Director – Africa for the International AIDS Vaccine Initiative, based in Nairobi, Kenya. He trained at Makerere University in Medicine and Surgery and also holds Master of Science at the London School of Hygiene and Tropical Medicine, UK, and PhD in Public Health from the City University, UK. Kamali is also an Honorary Professor, Department of Infectious Disease Epidemiology
at the London School of Hygiene and Tropical Medicine. Previously he was the Deputy Director and Head of HIV Epidemiology and Prevention Programme, MRC/UVRI Uganda Research Unit on AIDS, and Head of Department of Epidemiology, Uganda Virus Research Institute, Entebbe.
Anatoli has been involved in HIV/AIDS research since 1989, and he has led several prevention studies including early HIV vaccine trials, Ebola vaccine trials, phase III microbicide trials; prophylactic trials among HIV infected individuals, HIV epidemiological studies in general populations and high risk cohorts (female sex workers and fishing communities). He participates in several international scientific collaborations with institutions in the UK, USA and Africa. He was a member of the UK Microbicides Development Programme (MDP) that conducted a large efficacy and safety phase III microbicide trial for vaginally acquired HIV infection. He has served on several scientific boards for international organizations such as the WHO, UNAIDS, International Partnership for Microbicides, and Data and Safety Monitoring Board for the National Institute of Allergy and Infectious Diseases Division of AIDS (NIAID) Vaccine and Prevention. He has published over 100 scientific peer reviewed articles and book chapters.
Please RSVP to Ms. Necla Gunay (email@example.com) We look forward to seeing you on May 16th!